Get started
Award

K08-DK-076868

Funded outputs count: 8
Funder award ID: K08-DK-076868
OpenAlex ID: G693594045
Evolution of the primate trypanolytic factor APOL1
2014 · Russell Thomson, Giulio Genovese, et al. · Proceedings of the National Academy of Sciences · 225
Population-Based Risk Assessment of APOL1 on Renal Disease
2011 · David J. Friedman, Julia Kozlitina, et al. · Journal of the American Society of Nephrology · 226
Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients
2011 · David J. Friedman, Nisha Bhatt, et al. · Clinical Endocrinology · 9
The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans
2010 · Barry I. Freedman, Jeffrey B. Kopp, et al. · Journal of the American Society of Nephrology · 271
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 · Giulio Genovese, David J. Friedman, et al. · Science · 2,025
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
2009 · David J. Friedman, Beat M. Künzli, et al. · Proceedings of the National Academy of Sciences · 283
Klotho Variants and Chronic Hemodialysis Mortality
2009 · David J. Friedman, Maryam Afkarian, et al. · Journal of Bone and Mineral Research · 59
PDF
Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease
2008 · David J. Friedman, Matthew E. Talbert, et al. · Diabetes · 44
PDF
Year
Topic